论文部分内容阅读
目的:观察双氯芬酸钠栓对晚期原发性肝癌癌性发热和肝区疼痛的临床疗效。方法:对照观察双氯芬酸钠栓组和消炎痛片组各54例临床疗效及胃肠道副反应。结果:双氯芬酸钠栓组控制癌性发热有效率92.6%,控制肝区疼痛有效率77.1%,胃肠道副反应发生率7.4%;而对照组分别为77.1%,23.8%和55.6%。两组比较:P<0.01有显著性差异。结论:双氯芬酸钠栓对症治疗晚期原发性肝癌有显著疗效,胃肠道副反应发生率低,值得推广。
Objective: To observe the clinical efficacy of diclofenac sodium suppository in the treatment of advanced primary liver cancer with cancerous fever and liver pain. Methods: The control group was treated with diclofenac sodium suppository group and indomethacin group with 54 cases of clinical efficacy and gastrointestinal side effects. RESULTS: Diclofenac sodium suppository was effective in controlling the incidence of cancerous fever by 92.6%, and the effective rate of controlling hepatic pain was 77.1% and the incidence of gastrointestinal adverse reaction was 7.4%. The control group was 77.1%, 23.8% and 55.6% respectively. Comparison between the two groups: P <0.01 significant difference. CONCLUSION: Diclofenac sodium suppository has a significant effect on symptomatic treatment of advanced primary liver cancer with low incidence of gastrointestinal side effects and is worth promoting.